Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal International Journal of Economy, Education and Entrepreneurship (IJE3)
Lola Kambuno
Universitas Bhayangkara
Economics, Econometrics & Finance Education Other

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
THE EFFECT OF PROFITABILITY, LIQUIDITY, AND SOLVENCY ON FIRM VALUE IN PHARMACEUTICAL SUB-SECTOR COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE FOR THE PERIOD 2019-2024 Lola Kambuno; Matdio Siahaan; Wastam Wahyu Hidayat
International Journal of Economy, Education and Entrepreneurship (IJE3) Vol. 6 No. 2 (2026): International Journal of Economy, Education and Entrepreneurship
Publisher : Yayasan Education and Social Center

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53067/ije3.v6i2.497

Abstract

This study aims to examine the influence of key financial ratios, namely profitability, liquidity, and solvency, on the firm value of pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) during the 2019–2024 period. Profitability is measured using Return on Equity (ROE), liquidity is represented by the Current Ratio (CR), and solvency is measured using the Debt to Equity Ratio (DER). Firm value is assessed using the Price to Book Value (PBV) ratio. This research adopts a quantitative approach based on secondary data obtained from the annual financial statements of pharmaceutical sub-sector companies. The sample was selected through a purposive sampling technique according to predetermined criteria. Data analysis was conducted using multiple linear regression with the assistance of IBM SPSS Statistics version 26. The findings reveal that profitability (ROE) and solvency (DER) do not have a statistically significant effect on firm value. In contrast, liquidity (CR) has a positive and significant effect on firm value, indicating that stronger short-term financial capability enhances investor confidence and contributes to higher market valuation of pharmaceutical companies during the observation period.
Co-Authors Matdio Siahaan Wastam Wahyu Hidayat